10.1016/j.freeradbiomed.2015.01.011 86 ZitoE.ChinK
Obesity medications approved by the FDA for long-term use include orlistat (Xenical, Alli), phentermine-topiramate ER (Qsymia), naltrexone-bupropion ER (Contrave), liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound), and orforglipron (Foundayo)
This may vary from twice weekly to once every 2-4 weeks (source: The basics of treatment It is not understood why certain patients require more frequent B12 treatment
To reduce the development of adverse CVEs among patients with NAFLD and type 2 diabetes, it is also essential to have routine cardiovascular risk assessments and timely implementation of GLP-1RAs and SGLT2 inhibitors
The two peptides are clinically synergistic. No controlled combination trial was identified
Understanding both conditions is essential before considering any weight loss treatment